Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2015

Aug 19, 2015

33625_dirs_2015-08-19_8aebd375-716b-4437-b89a-81847439280f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2015-08-17

Reporting Person: Huggenberger Raymond (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-08-17 Common Stock M 57416 $0.60 Acquired 64224 Direct
2015-08-17 Common Stock S 38787 $50.1545 Disposed 25437 Direct
2015-08-17 Common Stock S 17713 $51.0011 Disposed 7724 Direct
2015-08-17 Common Stock S 916 $51.72 Disposed 6808 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-08-17 Stock Option (right to buy) $0.60 M 57416 Disposed 2020-02-24 Common Stock (57416) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2015.

F2: Represents the weighted average share price of an aggregate total of 38,787 shares sold in the price range of $49.68 to $50.67 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Represents the weighted average share price of an aggregate total of 17,713 shares sold in the price range of $50.70 to $51.675 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F4: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is February 24, 2010.